Stay updated on Fruquintinib and Sintilimab in Advanced Solid Tumors Clinical Trial
Sign up to get notified when there's something new on the Fruquintinib and Sintilimab in Advanced Solid Tumors Clinical Trial page.

Latest updates to the Fruquintinib and Sintilimab in Advanced Solid Tumors Clinical Trial page
- Check4 days agoNo Change Detected
- Check11 days agoNo Change Detected
- Check18 days agoChange DetectedThe page now shows revision v3.5.0. The previous revision v3.4.3 was removed.SummaryDifference0.1%

- Check26 days agoChange DetectedRevision tag updated from v3.4.2 to v3.4.3 on the page.SummaryDifference0.1%

- Check54 days agoChange DetectedAdded Revision: v3.4.2; an older notice about government funding and the previous Revision: v3.4.1 was removed. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.4%

- Check61 days agoChange DetectedA government funding lapse notice was added, indicating NIH operations status, and the site revision tag was updated to v3.4.1 (replacing v3.4.0).SummaryDifference0.4%

- Check68 days agoChange DetectedNat Commun publication entry for Fruquintinib plus sintilimab was added and updated from 'Online ahead of print' to the final citation, with related metadata such as a revision tag (v3.4.0) and 'Last Update Submitted that Met QC Criteria'. A new 'Show glossary' control was introduced, and 'No FEAR Act Data' information was added.SummaryDifference0.3%

- Check83 days agoChange DetectedThe page now displays Revision: v3.3.4, replacing the previous Revision: v3.3.3.SummaryDifference0.1%

Stay in the know with updates to Fruquintinib and Sintilimab in Advanced Solid Tumors Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Fruquintinib and Sintilimab in Advanced Solid Tumors Clinical Trial page.